Prognostic impact of missed chemotherapy doses during chemoradiation therapy for non–small cell lung cancer
American Journal of Clinical Oncology Mar 29, 2018
Deek MP, et al. - Non–small cell lung cancer (NSCLC) patients treated with definitive chemoradiation therapy (CRT) were examined, to determine the prognostic impact of missed chemotherapy administrations (MCA). Findings demonstrated a correlation of MCA with worse prognosis and increased mortality. Methods to reduce toxicity may improve administration of all chemotherapy doses and increase overall survival in NSCLC treated with CRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries